Clinical Trials Directory

Trials / Completed

CompletedNCT01019889

Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
480 (actual)
Sponsor
Korea Health Industry Development Institute · Other Government
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.

Detailed description

Upper respiratory tract infections (URTIs) are the most prevalent disease of human beings, it incur a significant health burden on populations in terms of human suffering and economic losses. Usually, antibiotic therapy is not helpful since most infections are virally induced. Over 200 serologically different viral types are responsible for human URTIs, so that preventions of URTIs including vaccination are impassable. SCRT and YPS are widely used to treat the respiratory disease. The objective of this study is to determine the efficacy of SCRT and YPS in symptomatic relief of patients with URTIs.

Conditions

Interventions

TypeNameDescription
DRUGSCRT4 capsules,three times daily, for 7days or within symptom disappearance
DRUGYPS4 capsules, three times daily, for 7days or within symptom disappearance
DRUGPlacebo4 capsules, three times daily, for 7days or within symptom disappearance

Timeline

Start date
2008-09-01
Primary completion
2009-06-01
Completion
2009-07-01
First posted
2009-11-25
Last updated
2012-04-06

Source: ClinicalTrials.gov record NCT01019889. Inclusion in this directory is not an endorsement.